Abnormal uterine architecture likely contributes to increased clinical pregnancy loss and reduced live birth in patients with Mullerian anomalies. Whether early trends in serum hCG levels predict
To develop a highly sensitive, non-invasive single-molecule native methylation sequencing assay for sperm-specific cell-free DNA (cfDNA) in seminal plasma that predicts sperm retrieval success
We hypothesize that trophoblast stem cells (TSC) are more sensitive than embryonic stem cells (ESC) to environmental stress stimuli, denoted by greater growth suppression or greater percent of
To validate the epigenetic sperm quality test ("SpermQT"), which measures dysregulated sperm DNA methylation, by assessing associations with pregnancy outcomes following ovarian stimulation
To assess the diagnostic performance of the beta human chorionic gonadotropin (β-HCG) discriminatory zone (DZ) in early pregnancy as proposed by the American College of Obstetrics and Gynecology
Is the oocyte yield after an ovarian stimulation (OS) treatment for IVF/ICSI influenced by the presence of luteinizing hormone (LH) in stimulation medication?
Many clinicians suspect immune problems when treating women with unexplained recurrent pregnancy loss (RPL); however, we lack evidence that immunotherapy helps. Although immune tolerance is
To assess the impact of different recombinant follicle-stimulating hormone (recFSH) dosages in ovarian stimulation (OS) on luteinizing hormone (LH)–receptor and FSH-receptor expression in
To identify differences in patient satisfaction between individuals who had in-person vs. telemedicine consultations at our large academic institution’s ambulatory fertility clinic.
Displaying 1421 to 1430 of 2642 records